In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.
 Lars Kober
Speaker
Lars Kober
Lars Kober Lars Kober

Rigshospitalet - Copenhagen University Hospital, Copenhagen (Denmark)

Specialities : Chronic Heart Failure , Acute Coronary Syndromes

Professor of Cardiology and Consultant, MD, D.Sci Graduated from University of Copenhagen and specialist in internal medicine and cardiology. Research interests: heart failure, coronary heart disease, atrial fibrillation and the cardiovascular consequences of comorbidities, with a focus on clinical trials and epidemiology. Main research activity is clinical trials and cardiovascular epidemiology. Serves as a member of the executive committee or steering committee in a number of large trials in heart failure and ischemic heart disease. The publication list encompasses more than 750 peer reviewed papers, and includes the 2015-2019 Highly Cited Researchers listing by Thomson Reuters.

16 presentations from this speaker

Role of ICD in primary prevention.

Event : ESC Congress 2020

  • Session : Interventions and Devices in Chronic Heart Failure
  • Speaker : L Kober (Copenhagen,DK)

Introduction - Who should receive the wearable cardioverter defibrillator? Evidence and risk stratification for prevention of sudden cardiac death

Event : Heart Failure 2019

  • Session : Who should receive the wearable cardioverter defibrillator? Evidence and risk stratification for prevention of sudden cardiac death
  • Speaker : L Kober (Copenhagen,DK)
  • Sponsored by Zoll

Patients with non-ischemic dilated cardiomyopathy still need primary prevention ICDs - CON

Event : ESC Congress 2019

  • Session : Controversies in management of atrial fibrillation and non-ischemic dilated cardiomyopathy
  • Speaker : L Kober (Copenhagen,DK)

State of the Art - Risk prediction in heart failure outcome

Event : ESC Congress 2019

  • Session : Risk prediction in heart failure outcome
  • Speaker : L Kober (Copenhagen,DK)

ICD and CRT in heart failure - Looking forward

Event : ESC Congress 2018

  • Session : ICD and CRT therapy in heart failure
  • Speaker : L Kober (Copenhagen,DK)

Primary prevention of sudden cardiac death in non-ischemic cardiomyopathy

Event : ESC Congress 2018

  • Session : Primary prevention of sudden cardiac death with the ICD: still "on" after DANISH?
  • Speaker : L Kober (Copenhagen,DK)

Selecting the right patient

Event : Heart Failure 2018

  • Session : Clinical dilemmas in cardiac device therapy
  • Speaker : L Kober (Copenhagen,DK)
  • Joint session with the European Heart Rhythm Association

ICD – When are they not needed?

Event : ESC Congress 2017

  • Session : Cardiomyopathy, sudden cardiac death and ICD
  • Speaker : L Kober (Copenhagen,DK)

ICD implantation for non-ischaemic cardiomyopathy – Represented in New England Journal of Medicine by the DANISH trial.

Event : ESC Congress 2017

  • Session : Highlights from the New England Journal of Medicine: editors’ choice
  • Speaker : L Kober (Copenhagen,DK)
  • Joint with the New England Journal of Medicine

Patients with non-ischaemic heart failure should receive an ICD - PRO.

Event : Heart Failure 2017

  • Session : Implantable Cardioverter Defibrillator (ICD)
  • Speaker : L Kober (Copenhagen,DK)

State of the Art: ICD therapy

Event : ESC Congress 2017

  • Session : ICD indications in 2017
  • Speaker : L Kober (Copenhagen,DK)

Updates on Implantable Cardiac Defibrillator (ICD) trials: the danish study and beyond.

Event : Heart Failure 2017

  • Session : Updates on risk guided stratification for primary prevention of sudden cardiac death in heart failure
  • Speaker : L Kober (Copenhagen,DK)
  • Sponsored by GE Healthcare

Aliskiren alone and in combination with enalapril, versus enalapril, in heart failure patients with diabetes.

Event : Heart Failure 2016

  • Session : Late Breaking Trials III: Focus on trial updates, registries and meta-analyses
  • Speaker : L Kober (Copenhagen,DK)

Heart failure patient with preserved ejection fraction and pulmonary oedema.

Event : ESC Congress 2014

  • Session : Guidelines on heart failure in daily practice
  • Speaker : L Kober (Copenhagen,DK)

Get your access to resources

Join now
  • 1ESC Professional Members – access all ESC Congress resources 
  • 2ESC Association Members (Ivory, Silver, Gold) – access your Association’s resources
  • 3Under 40 or in training - with a Combined Membership, access all resources
Join now

Our sponsors

ESC 365 is supported by Bayer, Boehringer Ingelheim and Lilly Alliance, Bristol-Myers Squibb and Pfizer Alliance, Novartis Pharma AG and Vifor Pharma in the form of educational grants. The sponsors were not involved in the development of this platform and had no influence on its content.

logo esc

Our mission: To reduce the burden of cardiovascular disease

Who we are